TTN non-truncating variants in DCM cohorts


The table below lists the 70 rare (MAF<0.0001 in ExAC) non-truncating TTN variants identified in a cohort of 156 DCM patients. When this rare variant frequency of 0.44870 is compared with a background population rate of 0.39200, there is a statistically significant case excess of 0.05670 (p<0.0001), which suggests that approximately of these variants may be pathogenic.


Source:      Combined (OMGL + LMM)     -     OMGL     -     LMM



No. Variant (CDS) Variant (Protein) Variant Type Cases (156)LMM class ExAC frequency
1. c.3469G>A p.V1157Imissense 1VUS0.000041
2. c.80608C>A p.Pro26870Thrmissense 1VUS0.000000
3. c.89947G>A p.V29983Mmissense 1VUS0.000099
4. c.6029A>G p.Y2010Cmissense 1VUS0.000008
5. c.11140A>G p.Ile3714Valmissense 1VUS0.000000
6. c.96140C>T p.T32047Mmissense 1VUS0.000057
7. c.5582G>A p.R1861Hmissense 1VUS0.000082
8. c.26765G>A p.Arg8922Glnmissense 1VUS0.000000
9. c.19015T>C p.Tyr6339Hismissense 1VUS0.000000
10. c.24344G>A p.S8115Nmissense 1VUS0.000083
11. c.47887A>G p.M15963Vmissense 1VUS0.000033
12. c.58705G>A p.D19569Nmissense 1VUS0.000017
13. c.68272G>A p.D22758Nmissense 1VUS0.000026
14. c.54685G>A p.V18229Mmissense 1VUS0.000091
15. c.74527A>G p.N24843Dmissense 1VUS0.000033
16. c.1186G>A p.A396Tmissense 1VUS0.000008
17. c.78980G>A p.R26327Qmissense 1VUS0.000049
18. c.91478A>G p.Glu30493Glymissense 1VUS0.000000
19. c.105590G>A p.G35197Dmissense 1VUS0.000041
20. c.94629A>G p.I31543Mmissense 1VUS0.000066
21. c.99814C>T p.L33272Fmissense 1VUS0.000009
22. c.25046C>G p.A8349Gmissense 1VUS0.000008
23. c.54167G>A p.R18056Qmissense 1VUS0.000026
24. c.62780G>A p.R20927Hmissense 1VUS0.000008
25. c.70181C>T p.T23394Mmissense 1VUS0.000024
26. c.77816A>C p.Asp25939Alamissense 1VUS0.000000
27. c.72985A>G p.Asn24329Aspmissense 1VUS0.000000
28. c.6478A>G p.T2160Amissense 1VUS0.000016
29. c.85195G>A p.E28399Kmissense 1VUS0.000016
30. c.20260A>G p.Lys6754Glumissense 1VUS0.000000
31. c.11450G>A p.G3817Dmissense 1VUS0.000017
32. c.89766G>C p.Lys29922Asnmissense 1VUS0.000000
33. c.96286G>A p.A32096Tmissense 1VUS0.000066
34. c.93472G>C p.Asp31158Hismissense 1VUS0.000000
35. c.107285G>A p.R35762Qmissense 1VUS0.000033
36. c.43019T>C p.I14340Tmissense 1VUS0.000008
37. c.48395G>A p.R16132Hmissense 1VUS0.000066
38. c.72488G>A p.R24163Hmissense 1VUS0.000054
39. c.58982G>A p.G19661Dmissense 1VUS0.000016
40. c.55139T>C p.I18380Tmissense 1VUS0.000050
41. c.2605A>T p.T869Smissense 1VUS0.000041
42. c.84523T>C p.Trp28175Argmissense 1VUS0.000000
43. c.98296G>T p.D32766Ymissense 1VUS0.000008
44. c.9674A>G p.N3225Smissense 1VUS0.000024
45. c.105630A>C p.Gln35210Hismissense 1VUS0.000000
46. c.98243G>A p.R32748Hmissense 1VUS0.000066
47. c.102638A>G p.N34213Smissense 1VUS0.000008
48. c.50647C>T p.Pro16883Sermissense 1VUS0.000000
49. c.39163A>G p.Lys13055Glumissense 1VUS0.000000
50. c.67147G>A p.G22383Rmissense 1VUS0.000058
51. c.63632T>C p.Val21211Alamissense 1VUS0.000000
52. c.58684A>G p.Ile19562Valmissense 1VUS0.000000
53. c.12037G>A p.Ala4013Thrmissense 1VUS0.000000
54. c.6941T>C p.I2314Tmissense 1VUS0.000008
55. c.5132C>T p.S1711Fmissense 1VUS0.000016
56. c.102428T>C p.M34143Tmissense 1VUS0.000074
57. c.93968C>T p.A31323Vmissense 1VUS0.000057
58. c.20742T>A p.Phe6914Leumissense 1VUS0.000000
59. c.99434G>A p.R33145Qmissense 1VUS0.000033
60. c.18663A>C p.E6221Dmissense 1VUS0.000099
61. c.22386T>G p.Asp7462Glumissense 1VUS0.000000
62. c.28754A>C p.Glu9585Alamissense 1VUS0.000000
63. c.37432C>T p.P12478Smissense 2VUS0.000000
64. c.62290G>C p.Glu20764Glnmissense 1VUS0.000000
65. c.57415A>C p.Ile19139Leumissense 1VUS0.000000
66. c.54091A>G p.S18031Gmissense 1VUS0.000008
67. c.64903C>T p.R21635Cmissense 1VUS0.000024
68. c.39749_39766delTTGCTCCTGAAGAGGAAA inframe 1VUS0.000000
69. c.15369_15371delGTT inframe 1VUS - favor pathogenic0.000000

References

1. Roddy Walsh, Kate L. Thomson, James S. Ware, Birgit H. Funke, Jessica Woodley, Karen J. McGuire, Francesco Mazzarotto, Edward Blair, Anneke Seller, Jenny C. Taylor, Eric V. Minikel, Exome Aggregation Consortium, Daniel G. MacArthur, Martin Farrall, Stuart A. Cook and Hugh Watkins. Reassessment of Mendelian gene pathogenicity using 7,855 cardiomyopathy cases and 60,706 reference samples. Genet Med. 2016 doi:10.1038/gim.2016.90.

2. Pugh TJ, Kelly MA, Gowrisankar S, Hynes E, Seidman MA, Baxter SM, Bowser M, Harrison B, Aaron D, Mahanta LM, Lakdawala NK, McDermott G, White ET, Rehm HL, Lebo M, Funke BH. The landscape of genetic variation in dilated cardiomyopathy as surveyed by clinical DNA sequencing. Genet Med. 2014 Aug;16(8):601-8.